E2E CLINICAL TRIALS Trademark

Trademark Overview


On Monday, January 14, 2019, a trademark application was filed for E2E CLINICAL TRIALS with the United States Patent and Trademark Office. The USPTO has given the E2E CLINICAL TRIALS trademark a serial number of 88260899. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, June 2, 2020. This trademark is owned by Medable, Inc.. The E2E CLINICAL TRIALS trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services

Conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials for others
e2e clinical trials

General Information


Serial Number88260899
Word MarkE2E CLINICAL TRIALS
Filing DateMonday, January 14, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, June 2, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBusiness consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services
Goods and ServicesConducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials for others
Pseudo MarkE TO E CLINICAL TRIALS

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, February 5, 2019
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 5, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMedable, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94301

Trademark Events


Event DateEvent Description
Tuesday, June 2, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, June 2, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, October 10, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, October 10, 2019FINAL REFUSAL E-MAILED
Thursday, October 10, 2019FINAL REFUSAL WRITTEN
Monday, September 30, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 27, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 27, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 27, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 27, 2019NON-FINAL ACTION E-MAILED
Wednesday, March 27, 2019NON-FINAL ACTION WRITTEN
Wednesday, March 27, 2019ASSIGNED TO EXAMINER
Tuesday, February 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 17, 2019NEW APPLICATION ENTERED IN TRAM